(-0.02%) 5 307.00 points
(0.00%) 40 143 points
(-0.01%) 18 502 points
(1.18%) $82.31
(-1.16%) $1.698
(0.91%) $2 232.80
(0.06%) $24.77
(0.17%) $911.25
(0.36%) $0.927
(0.59%) $10.83
(0.16%) $0.793
(-0.27%) $92.19
-0.16% KRW 125 200
Live Chart Being Loaded With Signals
Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella...
Stats | |
---|---|
Today's Volume | 20 351.00 |
Average Volume | 24 032.00 |
Market Cap | 1 428.93B |
EPS | KRW0 ( 2024-02-11 ) |
Next earnings date | ( KRW548.50 ) 2024-04-29 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW103.91 (0.08%) |
Volume Correlation
Green Cross Corporation Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Green Cross Corporation Correlation - Currency/Commodity
Green Cross Corporation Financials
Annual | 2023 |
Revenue: | KRW1 626.64B |
Gross Profit: | KRW458.69B (28.20 %) |
EPS: | KRW-2 333.42 |
Q4 | 2023 |
Revenue: | KRW404.94B |
Gross Profit: | KRW96.70B (23.88 %) |
EPS: | KRW-1 740.87 |
Q3 | 2023 |
Revenue: | KRW439.35B |
Gross Profit: | KRW140.85B (32.06 %) |
EPS: | KRW1 219.80 |
Q2 | 2023 |
Revenue: | KRW432.87B |
Gross Profit: | KRW140.79B (32.52 %) |
EPS: | KRW234.83 |
Financial Reports:
No articles found.
Green Cross Corporation
Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia A; prevention and treatment of bleeding episodes induced by hemophilia A and post-operative treatment; and treatment of neutropenia, hunter syndrome, and liver cancer, as well as treatment of anti-inflammation, pain relief, and osteoarthritis. In addition, the company provides over the counter drugs. It also exports its products to approximately 50 countries. The company has a licensing and collaboration agreement with Tottori University for development of GM1 gangliosidosis chaperone therapy. The company was formerly known as Sudo Microorganism Medical Supplies Company and changed its name to Green Cross Corporation in 1971. Green Cross Corporation was founded in 1967 and is headquartered in Yongin-si, South Korea. Green Cross Corporation is a subsidiary of Green Cross Holdings Corporation.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators